TrialJournal of the American Heart Association2016

Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Marwa A Sabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.